Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients

Overview of attention for article published in PharmacoEconomics, November 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 113 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer : Addendum

Cited by National Institute for Health and Care Excellence on 21 Mar 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

EndoPredict gene expression profiling assay for assessing risk of breast cancer recurrence

Cited by National Institute for Health and Care Excellence on 01 Nov 2015

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.